National and Kapodistrian University of Athens
Μελέτη του γενωμικού υπόβαθρου και της επίδρασης της νέο-επικουρικής θεραπείας σε ασθενείς με επιθηλιακό καρκίνο των ωοθηκών
Abstract
dc:descriptionBackground: Neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) and adjuvant chemotherapy is a therapeutic choice for women with advanced ovarian cancer. Whether NACT affects the tumour’s molecular profile has not been determined. Methods: This was a retrospective study of patients with advanced epithelial ovarian cancer treated with NACT at oncology departments affiliated with the Hellenic Cooperative Oncology Group (HeCOG). Tumor molecular profiling was performed from formalin-fixed and paraffin-embedded (FFPE) tumor pre- and post-NACT tissues. Homologous recombination deficiency (HRD), tumor infiltrating lymphocytes (TIL), tumor molecular alterations and tumor mutational burden (TMB) via next-generation sequencing analysis were assessed. Results: Overall, tumors from thirty-six patients were assessed; molecular profiling was evaluable in 20 paired tumor samples. HRD positivity exhibited no significant change between pre- and post-NACT tumors. BRCA1/2 mutational status remained constant irrespective of the treatment administration. Pre-NACT tumors tended to exhibit a lower percentage of intratumoral TILs compared to post-NACT tumors (p=0.004). Differences in the mutation profile between pre- and post-treatment tissue were observed in 33.33% (6/18) of the cases. The mean tumor cell content (TCC) (p-value: 0.0840) and the mean genomic instability score GIS (p-value: 0.0636) decreased slightly numerically after therapy. A moderate inverse relationship was observed between pre-NACT TMB and chemotherapy response score ( p-value: 0.038), indicating this correlation is statistically significant. Conclusion: The study provides insights into how NACT affects the tumor environment and mutational landscape. While BRCA1/2 and HRD status remain stable, increases in iTILs and changes in mutational profiles are observed post-treatment. This is a factor that should be considered in making subsequent therapeutic decisions. Prospective studies are needed to investigate the clinical significance of these findings
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Nikolaidi, Adamantia
- Νικολαΐδη, Αδαμαντία
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59002